Physical Exercise Positively Influences Breast Cancer Evolution

Clinical Breast Cancer

Volumn 17, Issue 6, 2017, Pages 408-417

  Adraskela, Kalliopi ^a   Veisaki, Eleftheria ^a   Koutsilieris, Michael ^a   Philippou, Anastassios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adiposity; Breast cancer survivors; Exercise training; Hormones; Inflammation; Physical activity

Indexed keywords

SEX HORMONE;

AFTERCARE; BONE ATROPHY; BREAST CANCER; BREAST CARCINOGENESIS; CACHEXIA; CANCER FATIGUE; CANCER PREVENTION; CANCER RISK; CANCER THERAPY; CARDIOTOXICITY; DNA METHYLATION; EPIGENETICS; EXERCISE; EXERCISE INTENSITY; HUMAN; KINESIOTHERAPY; MEDICAL CARE; MENTAL DISEASE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; POPULATION GROUP; REVIEW; RISK FACTOR; TELOMERE LENGTH; WEIGHT GAIN; BREAST TUMOR; FEMALE;

BREAST NEOPLASMS; EXERCISE; FEMALE; HUMANS;

EID: 85020383685     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2017.05.003     Document Type: Review

References (107)

1. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. 2007, American Institute for Cancer Research, Washington, DC Available at: http://www.aicr.org/assets/docs/pdf/reports/Second_Expert_Report.pdf.
2. International Agency for Research on Cancer, World Health Organization. Latest world cancer statistics [press release]. Available at: https://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf, 2013.
3. Pinto, B.M., Frierson, G.M., Rabin, C., et al. Home-based physical activity intervention for breast cancer patients. J Clin Oncol 23 (2005), 3577–3587.
4. Loprinzi, P.D., Cardinal, B.J., Winters-Stone, K., et al. Physical activity and the risk of breast cancer recurrence: a literature review. Oncol Nurs Forum 39 (2012), 269–274.
5. Baumann, F.T., Bloch, W., Weissen, A., et al. Physical activity in breast cancer patients during medical treatment and in the aftercare—a review. Breast Care (Basel) 8 (2013), 330–334.
6. McTiernan, A., Mechanisms linking physical activity with cancer. Nat Rev Cancer 8 (2008), 205–211.
7. Demark-Wahnefried, W., Campbell, K.L., Hayes, S.C., Weight management and its role in breast cancer rehabilitation. Cancer 118:8 suppl (2012), 2277–2287.
8. Alegre, M.M., Knowles, M.H., Robison, R.A., O'Neill, K.L., Mechanics behind breast cancer prevention—focus on obesity, exercise and dietary fat. Asian Pac J Cancer Prev 14 (2013), 2207–2212.
9. Armakolas, A., Stathopoulos, G.P., Nezos, A., et al. Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients. Oncol Rep 28 (2012), 2255–2263.
10. Stephens, P.J., Tarpey, P.S., Davies, H., et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 486 (2012), 400–404.
11. Papaoiconomou, E., Lymperi, M., Petraki, C., et al. Kiss-1/GPR54 protein expression in breast cancer. Anticancer Res 34 (2014), 1401–1407.
12. Skondra, M., Gkioka, E., Kostakis, I.D., et al. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription–polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features. Anticancer Res 34 (2014), 6691–6699.
13. Ford, D., Easton, D.F., Stratton, M., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62 (1998), 676–689.
14. Kumar, V., Abbas, A.K., Aster, J.C., Robbins and Cotran Pathologic Basis of Disease. 2014, Elsevier Health Sciences, Amsterdam.
15. Ohira, T., Schmitz, K.H., Ahmed, R.L., Yee, D., Effects of weight training on quality of life in recent breast cancer survivors: the Weight Training for Breast Cancer Survivors (WTBS) study. Cancer 106 (2006), 2076–2083.
16. Calle, E.E., Kaaks, R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4 (2004), 579–591.
17. De Pergola, G., Silvestris, F., Obesity as a major risk factor for cancer. J Obes, 2013, 2013, 291546.
18. Lynch, B.M., Neilson, H.K., Friedenreich, C.M., Physical activity and breast cancer prevention. Recent Results Cancer Res 186 (2011), 13–42.
19. Ahn, J., Schatzkin, A., Lacey, J.V. Jr., et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 167 (2007), 2091–2102.
20. Perez-Hernandez, A.I., Catalan, V., Gomez-Ambrosi, J., et al. Mechanisms linking excess adiposity and carcinogenesis promotion. Front Endocrinol (Lausanne), 5, 2014, 65.
21. Kershaw, E.E., Flier, J.S., Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004), 2548–2556.
22. Ahima, R.S., Adipose tissue as an endocrine organ. Obesity (Silver Spring) 14:suppl 5 (2006), 242S–249S.
23. Pollak, M., Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8 (2008), 915–928.
24. Key, T.J., Appleby, P.N., Reeves, G.K., Roddam, A.W., Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11 (2010), 530–542.
25. De Santi, M., Annibalini, G., Barbieri, E., et al. Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor. Cell Oncol (Dordr) 39 (2016), 149–159.
26. Christopoulos, P.F., Msaouel, P., Koutsilieris, M., The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer, 14, 2015, 43.
27. Lai, A., Sarcevic, B., Prall, O.W., Sutherland, R.L., Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1). J Biol Chem 276 (2001), 25823–25833.
28. Nalabolu, M.R., Palasamudram, K., Jamil, K., Adiponectin and leptin molecular actions and clinical significance in breast cancer. Int J Hematol Oncol Stem Cell Res 8 (2014), 31–40.
29. Kruk, J., Czerniak, U., Physical activity and its relation to cancer risk: updating the evidence. Asian Pac J Cancer Prev 14 (2013), 3993–4003.
30. Vona-Davis, L., Rose, D.P., Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14 (2007), 189–206.
31. Exley, M.A., Hand, L., O'Shea, D., Lynch, L., Interplay between the immune system and adipose tissue in obesity. J Endocrinol 223 (2014), R41–R48.
32. Kanda, H., Tateya, S., Tamori, Y., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116 (2006), 1494–1505.
33. Harvey, A.E., Lashinger, L.M., Hursting, S.D., The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 1229 (2011), 45–52.
34. + adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 59 (2010), 1648–1656.
35. Sousa, S., Brion, R., Lintunen, M., et al. Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res, 17, 2015, 101.
36. You, T., Arsenis, N.C., Disanzo, B.L., Lamonte, M.J., Effects of exercise training on chronic inflammation in obesity: current evidence and potential mechanisms. Sports Med 43 (2013), 243–256.
37. Golbidi, S., Laher, I., Exercise induced adipokine changes and the metabolic syndrome. J Diabetes Res, 2014, 2014, 726861.
38. Lyngso, D., Simonsen, L., Bulow, J., Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. J Physiol 543:pt 1 (2002), 373–378.
39. Matafome, P., Santos-Silva, D., Sena, C.M., Seica, R., Common mechanisms of dysfunctional adipose tissue and obesity-related cancers. Diabetes Metab Res Rev 29 (2013), 285–295.
40. Hosogai, N., Fukuhara, A., Oshima, K., et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56 (2007), 901–911.
41. Neilson, H.K., Conroy, S.M., Friedenreich, C.M., The influence of energetic factors on biomarkers of postmenopausal breast cancer risk. Curr Nutr Rep 3 (2014), 22–34.
42. Monninkhof, E.M., Velthuis, M.J., Peeters, P.H., et al. Effect of exercise on postmenopausal sex hormone levels and role of body fat: a randomized controlled trial. J Clin Oncol 27 (2009), 4492–4499.
43. Campbell, K.L., Foster-Schubert, K.E., Alfano, C.M., et al. Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol 30 (2012), 2314–2326.
44. Westerlind, K.C., Williams, N.I., Effect of energy deficiency on estrogen metabolism in premenopausal women. Med Sci Sports Exerc 39 (2007), 1090–1097.
45. Matthews, C.E., Fortner, R.T., Xu, X., et al. Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women. J Clin Endocrinol Metab 97 (2012), 3724–3733.
46. Neilson, H.K., Friedenreich, C.M., Brockton, N.T., Millikan, R.C., Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev 18 (2009), 11–27.
47. Ziech, D., Franco, R., Pappa, A., Panayiotidis, M.I., Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 711 (2011), 167–173.
48. Vera-Ramirez, L., Sanchez-Rovira, P., Ramirez-Tortosa, M.C., et al. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol 80 (2011), 347–368.
49. Na, H.K., Oliynyk, S., Effects of physical activity on cancer prevention. Ann N Y Acad Sci 1229 (2011), 176–183.
50. Artandi, S.E., DePinho, R.A., Telomeres and telomerase in cancer. Carcinogenesis 31 (2010), 9–18.
51. Shammas, M.A., Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care 14 (2011), 28–34.
52. Clavel-Chapelon, F., Gerber, M., Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis?. Breast Cancer Res Treat 72 (2002), 107–115.
53. Warren, M.P., Perlroth, N.E., The effects of intense exercise on the female reproductive system. J Endocrinol 170 (2001), 3–11.
54. Anothaisintawee, T., Wiratkapun, C., Lerdsitthichai, P., et al. Risk factors of breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health 25 (2013), 368–387.
55. World Health Organization. Estimated Incidence, Mortality and Prevalence Worldwide in 2012. 2012, International Agency for Research on Cancer; GLOBOCAN 2012; World Health Organization, Geneva, Switzerland.
56. Monninkhof, E.M., Elias, S.G., Vlems, F.A., et al. Physical activity and breast cancer: a systematic review. Epidemiology 18 (2007), 137–157.
57. Levi, F., Pasche, C., Lucchini, F., La Vecchia, C., Occupational and leisure time physical activity and the risk of breast cancer. Eur J Cancer 35 (1999), 775–778.
58. Brown, J.C., Winters-Stone, K., Lee, A., Schmitz, K.H., Cancer, physical activity, and exercise. Compr Physiol 2 (2014), 2775–2809.
59. Friedenreich, C.M., The role of physical activity in breast cancer etiology. Semin Oncol 37 (2010), 297–302.
60. Friedenreich, C.M., Cust, A.E., Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 42 (2008), 636–647.
61. American Cancer Society. Breast Cancer Facts and Figures, 2013-2014. 2013, American Cancer Society, Atlanta, GA Available at: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2013-2014.pdf.
62. Agrawal, S., Late effects of cancer treatment in breast cancer survivors. South Asian J Cancer 3 (2014), 112–115.
63. Melstrom, L.G., Melstrom, K.A. Jr., Ding, X.Z., Adrian, T.E., Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia. Histol Histopathol 22 (2007), 805–814.
64. Lira, F.S., Rosa, J.C., Zanchi, N.E., et al. Regulation of inflammation in the adipose tissue in cancer cachexia: effect of exercise. Cell Biochem Funct 27 (2009), 71–75.
65. Brandt, C., Pedersen, B.K., The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases. J Biomed Biotechnol, 2010, 2010, 520258.
66. Visovsky, C., Muscle strength, body composition, and physical activity in women receiving chemotherapy for breast cancer. Integr Cancer Ther 5 (2006), 183–191.
67. Clarkson, P.M., Kaufman, S.A., Should resistance exercise be recommended during breast cancer treatment?. Med Hypotheses 75 (2010), 192–195.
68. Alves, C.R., da Cunha, T.F., da Paixao, N.A., Brum, P.C., Aerobic exercise training as therapy for cardiac and cancer cachexia. Life Sci 125 (2015), 9–14.
69. Stene, G.B., Helbostad, J.L., Balstad, T.R., et al. Effect of physical exercise on muscle mass and strength in cancer patients during treatment—a systematic review. Crit Rev Oncol Hematol 88 (2013), 573–593.
70. Philippou, A., Barton, E.R., Optimizing IGF-I for skeletal muscle therapeutics. Growth Horm IGF Res 24 (2014), 157–163.
71. Stasi, R., Abriani, L., Beccaglia, P., et al. Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98 (2003), 1786–1801.
72. Sancho, A., Carrera, S., Arietaleanizbeascoa, M., et al. Supervised physical exercise to improve the quality of life of cancer patients: the EFICANCER randomised controlled trial. BMC Cancer, 15, 2015, 40.
73. Mishra, S.I., Scherer, R.W., Snyder, C., et al. The effectiveness of exercise interventions for improving health-related quality of life from diagnosis through active cancer treatment. Oncol Nurs Forum 42 (2015), E33–E53.
74. Meneses-Echavez, J.F., Gonzalez-Jimenez, E., Ramirez-Velez, R., Effects of supervised exercise on cancer-related fatigue in breast cancer survivors: a systematic review and meta-analysis. BMC Cancer, 15, 2015, 77.
75. Leach, H.J., Danyluk, J.M., Nishimura, K.C., Culos-Reed, S.N., Evaluation of a community-based exercise program for breast cancer patients undergoing treatment. Cancer Nurs 38 (2014), 417–425.
76. Mock, V., Pickett, M., Ropka, M.E., et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract 9 (2001), 119–127.
77. Lucius, K., Trukova, K., Integrative therapies and cardiovascular disease in the breast cancer population: a review, part 1. Integr Med (Encinitas) 14 (2015), 22–29.
78. Lucius, K., Trukova, K., Integrative therapies and cardiovascular disease in the breast cancer population: a review, part 2. Integr Med (Encinitas) 14 (2015), 33–40.
79. Wonders, K.Y., Reigle, B.S., Trastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise. Integr Cancer Ther 8 (2009), 17–21.
80. Goodwin, P.J., Ennis, M., Pritchard, K.I., et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 17 (1999), 120–129.
81. Kroenke, C.H., Chen, W.Y., Rosner, B., Holmes, M.D., Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23 (2005), 1370–1378.
82. Makari-Judson, G., Braun, B., Jerry, D.J., Mertens, W.C., Weight gain following breast cancer diagnosis: implication and proposed mechanisms. World J Clin Oncol 5 (2014), 272–282.
83. Demark-Wahnefried, W., Platz, E.A., Ligibel, J.A., et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev 21 (2012), 1244–1259.
84. Wang, J.S., Cai, H., Wang, C.Y., et al. Body weight changes in breast cancer patients following adjuvant chemotherapy and contributing factors. Mol Clin Oncol 2 (2014), 105–110.
85. Playdon, M.C., Bracken, M.B., Sanft, T.B., et al. Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis. J Natl Cancer Inst, 107, 2015, djv275.
86. Lahart, I.M., Metsios, G.S., Nevill, A.M., Carmichael, A.R., Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol 54 (2015), 635–654.
87. Garg, A., Leitzel, K., Ali, S., Lipton, A., Antiresorptive therapy in the management of cancer treatment–induced bone loss. Curr Osteoporos Rep 13 (2015), 73–77.
88. Tiong, V., Rozita, A.M., Taib, N.A., et al. Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer. World J Surg 38 (2014), 2288–2296.
89. Oostra, D.R., Lustberg, M.B., Reinbolt, R.E., et al. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. Mol Cell Endocrinol 402 (2015), 51–56.
90. Katopodis, H., Philippou, A., Tenta, R., et al. MG-63 osteoblast-like cells enhance the osteoprotegerin expression of PC-3 prostate cancer cells. Anticancer Res 29 (2009), 4013–4018.
91. Kalder, M., Hadji, P., Breast cancer and osteoporosis—management of cancer treatment–induced bone loss in postmenopausal women with breast cancer. Breast Care (Basel) 9 (2014), 312–317.
92. Reich, M., Lesur, A., Perdrizet-Chevallier, C., Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 110 (2008), 9–17.
93. Galiano-Castillo, N., Ariza-Garcia, A., Cantarero-Villanueva, I., et al. Depressed mood in breast cancer survivors: associations with physical activity, cancer-related fatigue, quality of life, and fitness level. Eur J Oncol Nurs 18 (2014), 206–210.
94. Payne, J.K., Held, J., Thorpe, J., Shaw, H., Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol Nurs Forum 35 (2008), 635–642.
95. Alfano, C.M., Lichstein, K.L., Vander Wal, G.S., et al. Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life. Breast Cancer Res Treat 130 (2011), 243–254.
96. Fiorentino, L., Ancoli-Israel, S., Insomnia and its treatment in women with breast cancer. Sleep Med Rev 10 (2006), 419–429.
97. Rogers, L.Q., Fogleman, A., Trammell, R., et al. Inflammation and psychosocial factors mediate exercise effects on sleep quality in breast cancer survivors: pilot randomized controlled trial. Psychooncology 24 (2015), 302–310.
98. Courneya, K.S., Segal, R.J., Mackey, J.R., et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25 (2007), 4396–4404.
99. Egan, M.Y., McEwen, S., Sikora, L., et al. Rehabilitation following cancer treatment. Disabil Rehabil 35 (2013), 2245–2258.
100. Spence, R.R., Heesch, K.C., Brown, W.J., Exercise and cancer rehabilitation: a systematic review. Cancer Treat Rev 36 (2010), 185–194.
101. Volaklis, K.A., Halle, M., Tokmakidis, S.P., Exercise in the prevention and rehabilitation of breast cancer. Wien Klin Wochenschr 125 (2013), 297–301.
102. Harris, S.R., Schmitz, K.H., Campbell, K.L., McNeely, M.L., Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals. Cancer 118:8 suppl (2012), 2312–2324.
103. Campbell, K.L., Neil, S.E., Winters-Stone, K.M., Review of exercise studies in breast cancer survivors: attention to principles of exercise training. Br J Sports Med 46 (2012), 909–916.
104. Kim, J., Choi, W.J., Jeong, S.H., The effects of physical activity on breast cancer survivors after diagnosis. J Cancer Prev 18 (2013), 193–200.
105. Battaglini, C.L., Mills, R.C., Phillips, B.L., et al. Twenty-five years of research on the effects of exercise training in breast cancer survivors: a systematic review of the literature. World J Clin Oncol 5 (2014), 177–190.
106. Winters-Stone, K.M., Dobek, J., Nail, L.M., et al. Impact + resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial. Osteoporos Int 24 (2013), 1637–1646.
107. Martyn-St James, M., Carroll, S., A meta-analysis of impact exercise on postmenopausal bone loss: the case for mixed loading exercise programmes. Br J Sports Med 43 (2009), 898–908.